Biomarker-driven targeted therapies for gastric/gastro-esophageal junction malignancies

Salem Kim1, Afsaneh Barzi2, Lakshmi Rajdev1

  • 1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY.

Seminars in Oncology
|September 29, 2018
PubMed

Insights

Advanced gastric and gastroesophageal cancers exhibit aggressive traits and drug resistance. This review explores recent progress in targeted therapies for these challenging malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Gastroesophageal malignancies are characterized by significant genetic and molecular alterations.
  • These alterations contribute to aggressive disease progression, rapid metastasis, and early drug resistance.
  • Many patients present with advanced or metastatic disease requiring systemic treatment.

Purpose of the Study:

  • To review recent advancements in targeted therapy development for advanced gastric and gastroesophageal cancer.
  • To highlight novel therapeutic strategies beyond traditional chemotherapy.

Main Methods:

  • Literature review of recent studies and clinical trials.
  • Analysis of emerging targeted therapies and their mechanisms of action.
  • Synthesis of data on targeted agents for advanced gastric and gastroesophageal cancer.

Main Results:

  • Identification of several promising targeted therapies currently in development or clinical use.
  • Discussion of specific molecular targets and associated drug candidates.
  • Overview of the potential impact of targeted therapies on patient outcomes.

Conclusions:

  • Targeted therapies represent a significant advancement in treating advanced gastric and gastroesophageal cancers.
  • Further research and clinical trials are crucial to optimize the use of these novel agents.
  • Personalized medicine approaches hold promise for improving treatment efficacy and patient survival.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Gastric Motility01:16

Gastric Motility

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
3.2K
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.5K
P-N junction01:11

P-N junction

A p-n junction is formed when p-type and n-type semiconductor materials are joined together. At the interface of the p-n junction, holes from the p-side and electrons from the n-side begin to diffuse into the opposite sides due to the concentration gradient. This diffusion of carriers leads to a region around the junction where there are no free charge carriers, known as the depletion region. The charge density within the depletion region for the n-side and p-side can be described by the...
1.2K
Gastric Emptying01:16

Gastric Emptying

Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
3.8K
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
612